Patents
Sitemap › C07 - Organic chemistry › C07C - Acyclic or carbocyclic compounds › C07C 275 - Derivatives of urea, i.e. compounds containing any of the groups the nitrogen atoms not being part of nitro or nitroso groups
Patents for C07C 275 - Derivatives of urea, i.e. compounds containing any of the groups the nitrogen atoms not being part of nitro or nitroso groups (9,848)
12/2003
12/23/2003US6667404 Retroviral protease inhibiting compounds
12/23/2003US6667331 Non-peptidyl inhibitors of VLA-4 dependent cell binding useful in treating inflammatory, autoimmune, and respiratory diseases
12/18/2003WO2003104188A1 N-benzoylureidocinnamate derivatives, method for production and use thereof
12/18/2003WO2003103651A1 Compounds of the formu;a r1-x-y-z-nr2r3 as abca-1 elevating agents against cad or atherosclerosis
12/18/2003WO2003072537A3 Selective protein tyrosine phosphatatase inhibitors
12/18/2003US20030232868 Cyclic carboxylic acids as integrin antagonists
12/18/2003US20030232815 Non-peptidic cyclophilin binding compounds and their use
12/18/2003CA2488760A1 N-benzoylureidocinnamate derivatives, method for production and use thereof
12/17/2003EP1371637A1 Continuous process for the production of MDI allophanates
12/17/2003EP1370522A1 Phenyl derivatives and their use in the treatment of thromboembolic disorders or tumours
12/17/2003EP1370520A1 Aryl and biaryl compounds having mch modulatory activity
12/17/2003EP1370519A1 Synthetic excitatory amino acids
12/17/2003EP1370256A1 Novel inhibitors of formation of advanced glycation endproducts (ages)
12/17/2003CN1131206C Improved urea synthetic method and its equipment
12/16/2003US6664293 For treatment and/or prevention of disorders in the central nervous system, particularly amnesia, dementia, Alzheimer's dementia
12/16/2003US6664272 Such as 1,5-Bis-(2, 4-difluorophenyl)penta-1,4-diene-3 -one; administering to inhibit tissue factor and vascular endothelial growth factor (VEGF) production in cancerous tissue
12/16/2003US6664262 N-methoxymethyl-5,5-diphenylbarbituric acid
12/13/2003CA2430650A1 Continuous process for the production of mdi allophanates
12/11/2003WO2003102592A2 Selective binding and analysis of macromolecules: quantitative analysis of proteins in complex mixtures
12/11/2003WO2003102044A2 Low-cure powder coatings and methods for using the same
12/11/2003WO2003101927A1 Compounds, compositions and methods for the treatment of amyloid diseases and synucleinopathies such as alzheimer's disease, type 2 diabetes, and parkinson's disease
12/11/2003WO2003004460A3 Succinic acid derivatives
12/11/2003WO2002008174A8 Phenylethylamine derivatives and their use in the treatment of melanoma
12/11/2003US20030228573 Contacting test compound with Gag283 and determining its ability to bind to the apical cleft near the C-terminal domain; use in treatment of Acquired Immunodeficiency Syndrome (AIDS)
12/11/2003US20030228468 Cure at low temperature in the absence of a crosslinking agent and/or accelerator; catalyst initiates self-curing of the polyepoxide; aminoalkyl carbamate or aminoalkyl urea compound is reaction product of diisocyante and an amine or alcohol
12/10/2003EP0933346B1 NOVEL p-TERPHENYL COMPOUNDS
12/09/2003US6660879 Use of the compound in clinical conditions associated with insulin resistance.
12/09/2003US6660284 Anthraquinone compounds, manufacturing process, use as pigments and cosmetic composition
12/04/2003WO2003099776A1 Calcium receptor modulating arylalkylamines
12/04/2003WO2003057169A3 4-dedimethylamino tetracycline compounds
12/04/2003WO2003034989A3 α-HYDROXYARYLBUTANAMINE INHIBITORS OF ASPARTYL PROTEASE
12/04/2003US20030225298 Reacting bis-(phosophonomethyl)urea or urea with carbon monoxide and formaldehyde in the presence of catalysts and solvents to form N-(phosphonomethyl)glycine
12/04/2003US20030225285 Oxidizing a protected aminoalcohol to a chiral protected aminoaldehyde and diastereoselectively forming the aminoepoxide from said aminoaldehyde with an organometallic methylene-adding reagent in an appropriate solvent
12/04/2003US20030225283 2-Substituted phenyl,3-polar ring,N-heroaromatic propion-amides, e.g., 1-(2-(3,4-Dichlorophenyl)-3-(tetrahydro-furan-2-yl)-propionyl)-3- methylurea; antidiabetic agents; increase the flux of glucose metabolism in beta-cells and hepatocytes
12/03/2003EP1366021A2 Substituted diarylureas as stimulators for fas-mediated apoptosis
12/03/2003EP1366020A1 Urea derivatives having vanilloid receptor (vr1) antagonist activity
12/03/2003EP1144476B1 Coating agents which can be hardened by the addition of isocyanate groups as well as by the radiation-induced addition of activated c-c double covalent bonds
12/02/2003US6657083 5-acylamino-2-amino-4-substituted-phenol compounds and method of using them
12/02/2003US6656971 Non-peptidic small organic compounds having an affinity for cyclophilin (CyP)-type immunophilins; inhibiting their peptidyl-prolyl isomerase activity; treating variety of medical conditions
12/02/2003US6656884 Use as herbicides or for the desiccation or defoliation of plants
12/02/2003US6656498 Cationic liposomes for gene transfer
12/02/2003CA2284446C New cyclic cycloalkylene chain derivatives, their preparation process and pharmaceutical compounds containing them
11/2003
11/27/2003WO2003097619A1 Glucagon antagonists/inverse agonists
11/27/2003WO2003097587A2 Gelling agents
11/27/2003WO2003097586A1 Aminotetralin-derived urea modulators of vanilloid vr1 receptor
11/27/2003WO2003014064A8 Naphthylurea and naphthylacetamide derivatives as vanilloid receptor 1 (vr1) antagonists
11/27/2003WO2002057242A3 Urea derivatives as integrin alpha 4 antagonists
11/27/2003US20030220350 For example, 3-(4-((N-(5-chlorobenzo(B)thiophen-3-carbonyl)-N-(2,2-diphenyl ethyl)amino)methyl)benzoylamino)propionic acid; for treatment or prevention of glucagon-mediated diseases such as diabetes
11/27/2003US20030220347 Compounds and methods for treatment of asthma, allergy and inflammatory disorders
11/27/2003CA2486092A1 Aminotetralin-derived urea modulators of vanilloid vr1 receptor
11/26/2003EP1364941A1 Gelling agents
11/26/2003CN1458922A Urea derivative and adhesive-molecule inhibitor containing same as ctive ingredient
11/25/2003US6653505 Oxidation resistance
11/25/2003US6653326 Hydroxylamine derivatives useful for enhancing the molecular chaperon production and the preparation thereof
11/25/2003US6653258 Pyridinyl-substituted- methyl 3-methoxy-2-phenylacrylate derivatives; agricultural miticides and nematocides
11/20/2003WO2003095438A1 Substituted phenylacetamides and their use as glucokinase activators
11/20/2003WO2003095420A1 Hydroxy tetrahydro-naphthalenylurea derivatives
11/20/2003WO2003051276A3 Therapeutic heterocycles
11/20/2003WO2002002506A8 Compounds to treat alzheimer's disease
11/20/2003WO2002002505A8 Compounds to treat alzheimer's disease
11/20/2003US20030216434 Cyclic derivatives as modulators of chemokine receptor activity
11/20/2003US20030216370 Antidiabetic agents
11/19/2003EP1362846A1 Aminoethanol derivatives
11/19/2003EP1361878A1 Treatment of parkinson's disease by the combined action of a compound with neurotrophic activity and a compound enhancing the dopamine activity
11/19/2003EP1361874A1 Treatment of diseases characterized by excessive or insufficient cell death
11/18/2003US6649691 Wet adhesion monomer and derived copolymers for latex paints
11/18/2003US6649658 (−)-Verbenone derivatives
11/18/2003US6649641 Glucagon antagonists/inverse agonists
11/18/2003US6649616 For therapy and prophylaxis of cardiovascular disorders caused by ischaemia
11/13/2003WO2003093250A2 Positive allosteric modulators of the nicotinic acetylcholine receptor
11/13/2003WO2003093224A1 Amidinylphenyl compounds and their use as fungicides
11/13/2003WO2003092670A1 Bombesin antagonists
11/13/2003WO2003024448A3 Inhibitors of histone deacetylase
11/13/2003WO2002098849A3 Hydroxy alkyl amine derivatives as beta-secretase inhibitors and their use for the treatment of alzheimer’s disease and similar diseases
11/13/2003WO2002002520A8 Compounds to treat alzheimer's disease
11/13/2003WO2001040188A8 Curcumin analogues for treating cancer
11/13/2003CA2484582A1 Bombesin antagonists
11/12/2003EP1360173A2 Trisubstituted carbocyclic cyclophilin binding compounds and their use
11/12/2003EP1360172A1 Ppar agonists
11/12/2003EP0760657B1 Novel potent inducers of terminal differentiation and methods of use thereof
11/12/2003CN1455767A Substituted phenylcyclohexane carboxylic acid amides and use thereof
11/11/2003US6646149 Derivitives of spermine or its N12-t-butyl carbamate
11/11/2003US6645968 Potassium channel openers
11/06/2003WO2003091287A1 Incorporable photoinitiator
11/06/2003WO2003091204A1 Phenethanolamine derivatives
11/06/2003WO2003066889A3 Assay for acytyltransferase or deacetylase activity
11/06/2003US20030207939 Novel 3-substituted urea derivatives and medicinal use thereof
11/06/2003US20030207934 Such as ((S)-1-benzyl-2-oxo-but-3-enyl)-carbamic acid tert-butyl ester; for treating human immunodeficiency virus; antimalarial agents
11/06/2003US20030207895 Tissue factor antagonists and methods of use thereof
11/06/2003US20030207894 1,4-Disubstituted benzenes as insecticides
11/06/2003US20030207872 Omega-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
11/06/2003CA2483004A1 Incorporable photoinitiator
11/05/2003EP1358171A2 Novel urea derivatives, method for preparing same, use thereof as medicines, pharmaceutical compositions and novel use
10/2003
10/30/2003WO2003089615A2 Antiviral inhibitions of capsid proteins
10/30/2003WO2003089405A1 Derivatives of hydroxyphenyl, a method for preparing thereof and their pharmaceutical composition
10/30/2003WO2003089404A1 Naphthalene amides as potassium channel openers
10/30/2003WO2003088915A2 Novel sodium channel blockers
10/30/2003WO2003066579A3 Novel bicyclic hydroxamates as inhibitors of histone deacetylase
10/30/2003US20030204113 3-Methoxybenzyl thiourea derivatives and improved lipid compositions containing same
10/30/2003US20030203946 Glucagon antagonists/inverse agonists
1 ... 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 ... 99